Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease

Abstract

Faecal calprotectin proved to be an even stronger predictor of clinical relapse in UC than in CD, which makes the test a promising non-invasive tool for monitoring and optimising therapy.